12-121858702-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002150.3(HPD):​c.15T>G​(p.Ser5Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.006 in 1,613,958 control chromosomes in the GnomAD database, including 176 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0066 ( 17 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 159 hom. )

Consequence

HPD
NM_002150.3 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.319

Publications

7 publications found
Variant links:
Genes affected
HPD (HGNC:5147): (4-hydroxyphenylpyruvate dioxygenase) The protein encoded by this gene is an enzyme in the catabolic pathway of tyrosine. The encoded protein catalyzes the conversion of 4-hydroxyphenylpyruvate to homogentisate. Defects in this gene are a cause of tyrosinemia type 3 (TYRO3) and hawkinsinuria (HAWK). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
HPD Gene-Disease associations (from GenCC):
  • tyrosinemia type III
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • hawkinsinuria
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028541684).
BP6
Variant 12-121858702-A-C is Benign according to our data. Variant chr12-121858702-A-C is described in ClinVar as Benign. ClinVar VariationId is 235261.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.065 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPDNM_002150.3 linkc.15T>G p.Ser5Arg missense_variant Exon 2 of 14 ENST00000289004.8 NP_002141.2 P32754
HPDNM_001171993.2 linkc.-103T>G 5_prime_UTR_variant Exon 4 of 16 NP_001165464.1 P32754-2
TIALDXR_002957437.2 linkn.614+864A>C intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPDENST00000289004.8 linkc.15T>G p.Ser5Arg missense_variant Exon 2 of 14 1 NM_002150.3 ENSP00000289004.4 A0A0B4J1R4

Frequencies

GnomAD3 genomes
AF:
0.00653
AC:
992
AN:
152006
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.00440
Gnomad AMR
AF:
0.0294
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0106
Gnomad FIN
AF:
0.00161
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00585
Gnomad OTH
AF:
0.00908
GnomAD2 exomes
AF:
0.0142
AC:
3560
AN:
251476
AF XY:
0.0121
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.0735
Gnomad ASJ exome
AF:
0.00228
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00129
Gnomad NFE exome
AF:
0.00537
Gnomad OTH exome
AF:
0.00945
GnomAD4 exome
AF:
0.00593
AC:
8675
AN:
1461834
Hom.:
159
Cov.:
32
AF XY:
0.00593
AC XY:
4314
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.00111
AC:
37
AN:
33480
American (AMR)
AF:
0.0670
AC:
2998
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00222
AC:
58
AN:
26134
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.00955
AC:
824
AN:
86254
European-Finnish (FIN)
AF:
0.00154
AC:
82
AN:
53420
Middle Eastern (MID)
AF:
0.00798
AC:
46
AN:
5768
European-Non Finnish (NFE)
AF:
0.00386
AC:
4296
AN:
1111964
Other (OTH)
AF:
0.00546
AC:
330
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
563
1126
1690
2253
2816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00659
AC:
1003
AN:
152124
Hom.:
17
Cov.:
32
AF XY:
0.00678
AC XY:
504
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.00116
AC:
48
AN:
41494
American (AMR)
AF:
0.0301
AC:
460
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5168
South Asian (SAS)
AF:
0.0104
AC:
50
AN:
4808
European-Finnish (FIN)
AF:
0.00161
AC:
17
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00585
AC:
398
AN:
67996
Other (OTH)
AF:
0.00899
AC:
19
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
48
96
143
191
239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00647
Hom.:
20
Bravo
AF:
0.00874
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00477
AC:
41
ExAC
AF:
0.0126
AC:
1532
Asia WGS
AF:
0.00606
AC:
21
AN:
3478
EpiCase
AF:
0.00502
EpiControl
AF:
0.00563

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 17, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hawkinsinuria Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Tyrosinemia type III Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Tyrosinemia type III;C2931042:Hawkinsinuria Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.027
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.13
N
LIST_S2
Uncertain
0.96
D
MetaRNN
Benign
0.0029
T
MetaSVM
Benign
-1.1
T
PhyloP100
-0.32
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.061
Sift
Benign
0.040
D
Sift4G
Benign
0.16
T
Vest4
0.13
MutPred
0.26
Loss of ubiquitination at K7 (P = 0.0192);
MPC
0.47
ClinPred
0.00098
T
GERP RS
-3.7
PromoterAI
0.035
Neutral
gMVP
0.29
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35849100; hg19: chr12-122296608; API